A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: Potential applications for preventing HIV-1 infection

Fitoterapia

Volumn 83, Issue 2, 2012, Pages 348-355

  Yang, Jie ^a   Li, Lin ^a   Tan, Suiyi ^a   Jin, Hong ^a   Qiu, Jiayin ^a   Mao, Qinchao ^a   Li, Runming ^a   Xia, Chenglai ^a   Jiang, Zhi Hong ^c   Jiang, Shibo ^a,b   Liu, Shuwen ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Entry inhibitors; HIV; Microbicides; Prevention; Theaflavin derivatives

Indexed keywords

ANTIGEN P24; FLAVONOID; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; RNA DIRECTED DNA POLYMERASE; TFMIX; THEAFLAVIN; THEAFLAVIN 3' GALLATAE; THEAFLAVIN 3,3' DIGALLATE; THEAFLAVINE 3 GALLATE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RETENTION; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; IN VITRO STUDY; MEMBRANE FUSION; MOLECULAR WEIGHT; NONHUMAN; PH; PRIORITY JOURNAL; VIRUS INHIBITION;

CAMELLIA SINENSIS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856012010     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.11.016     Document Type: Article

References (30)

1. K.Q. Abdool, K.S. Abdool, J.A. Frohlich, A.C. Grobler, C. Baxter, and L.E. Mansoor Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
2. V.A. Johnson, F. Brun-Vezinet, B. Clotet, B. Conway, R.T. D'Aquila, and L.M. Demeter Drug resistance mutations in HIV-1 Top HIV Med 11 2003 215 221
3. D.D. Richman, S.C. Morton, T. Wrin, N. Hellmann, S. Berry, and M.F. Shapiro The prevalence of antiretroviral drug resistance in the United States AIDS 18 2004 1393 1401 (Pubitemid 38925131)
4. R. Subbaraman, S.K. Chaguturu, K.H. Mayer, T.P. Flanigan, and N. Kumarasamy Adverse effects of highly active antiretroviral therapy in developing countries Clin Infect Dis 45 2007 1093 1101 (Pubitemid 47580363)
5. L.C. Rohan, B.J. Moncla, N.A.R. Kunjara, M. Cost, Y. Huang, and F. Gai In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide PLoS One 5 2010 e9310
6. D. Yu, S.L. Morris-Natschke, and K.H. Lee New developments in natural products-based anti-AIDS research Med Res Rev 27 2007 108 132 (Pubitemid 44975188)
7. M. Friedman Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas Mol Nutr Food Res 51 2007 116 134 (Pubitemid 46144767)
8. P. Cos, L. Maes, A. Vlietinck, and L. Pieters Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998-2007) Planta Med 74 2008 1323 1337
9. H. Duan, Y. Takaishi, Y. Imakura, Y. Jia, D. Li, and L.M. Cosentino Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: a new class of potent anti-HIV agents J Nat Prod 63 2000 357 361 (Pubitemid 30173693)
10. Y. Kashiwada, A. Aoshima, Y. Ikeshiro, Y.P. Chen, H. Furukawa, and M. Itoigawa Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids Bioorg Med Chem 13 2005 443 448 (Pubitemid 39642926)
11. S. Liu, S. Jiang, Z. Wu, L. Lv, J. Zhang, and Z. Zhu Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte Life Sci 71 2002 1779 1791 (Pubitemid 34879160)
12. G. Fassina, A. Buffa, R. Benelli, O.E. Varnier, D.M. Noonan, and A. Albini Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent AIDS 16 2002 939 941 (Pubitemid 34409024)
13. K. Kawai, N.H. Tsuno, J. Kitayama, Y. Okaji, K. Yazawa, and M. Asakage Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding J Allergy Clin Immunol 112 2003 951 957 (Pubitemid 37412065)
14. S. Liu, H. Lu, Q. Zhao, Y. He, J. Niu, and A.K. Debnath Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 Biochim Biophys Acta 1723 2005 270 281 (Pubitemid 40744696)
15. D.C. Chan, D. Fass, J.M. Berger, and P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273 (Pubitemid 27199898)
16. M. Lu, S.C. Blacklow, and P.S. Kim A trimeric structural domain of the HIV-1 transmembrane glycoprotein Nat Struct Biol 2 1995 1075 1082
17. S. Jiang, K. Lin, and M. Lu A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein J Virol 72 1998 10213 10217 (Pubitemid 28520893)
18. K. Wang, Z. Liu, J. Huang, and Y. Gong Determination of theaflavins in black tea by high performance liquid chromatography Se Pu 22 2004 151 153
19. S.B. Jiang, K. Lin, and A.R. Neurath Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 J Exp Med 174 1991 1557 1563
20. S. Jiang, H. Lu, S. Liu, Q. Zhao, Y. He, and A.K. Debnath N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion Antimicrob Agents Chemother 48 2004 4349 4359 (Pubitemid 39434898)
21. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
22. S. Jiang, K. Lin, N. Strick, and A.R. Neurath HIV-1 inhibition by a peptide Nature 365 1993 113
23. Q. Zhao, J.T. Ernst, A.D. Hamilton, A.K. Debnath, and S. Jiang XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41 AIDS Res Hum Retroviruses 18 2002 989 997
24. S. Jiang, K. Lin, L. Zhang, and A.K. Debnath A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody J Virol Methods 80 1999 85 96 (Pubitemid 29248906)
25. S. Liu, Q. Zhao, and S. Jiang Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors Peptides 24 2003 1303 1313 (Pubitemid 38045537)
26. D. Eggink, C.E. Baldwin, Y. Deng, J.P. Langedijk, M. Lu, and R.W. Sanders Selection of T1249-resistant human immunodeficiency virus type 1 variants J Virol 82 2008 6678 6688 (Pubitemid 351875144)
27. J.W. Jhoo, C.Y. Lo, S. Li, S. Sang, C.Y. Ang, and T.M. Heinze Stability of black tea polyphenol, theaflavin, and identification of theanaphthoquinone as its major radical reaction product J Agric Food Chem 53 2005 6146 6150 (Pubitemid 41126660)
28. R.M. Grant, J.R. Lama, P.L. Anderson, V. McMahan, A.Y. Liu, and L. Vargas Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2010 2587 2599
29. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684 (Pubitemid 28257575)
30. E.A. Berger HIV entry and tropism: the chemokine receptor connection AIDS 11 1997 S3 S16 Suppl A